About Ireland Cancer Center Landerbrook Health Center
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
SWOG Cancer Research Network
9
Bayer
2
Alliance for Clinical Trials in Oncology
1
ECOG-ACRIN Cancer Research Group
1
National Cancer Institute (NCI)
1
Clinical Trials at Ireland Cancer Center Landerbrook Health Center
During the past decade, Ireland Cancer Center Landerbrook Health Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 12 clinical trials were completed, i.e. on
average, 240% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 10 clinical trials were completed. i.e. 500%
of trials that started reached the finish line.
Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer
2014-09-01
2019-06-01
Completed
53
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Ireland Cancer Center Landerbrook Health Center" #1 sponsor was "SWOG Cancer Research Network" with 9 trials, followed by "Bayer" with 2 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "National Cancer Institute (NCI)"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ireland Cancer Center Landerbrook Health Center"
#1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Biologics, Inc." with 1 trials as a collaborator and "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Ireland Cancer Center Landerbrook Health Center
According to Clinical.Site data, the most researched conditions in "Ireland Cancer Center Landerbrook Health Center" are
"Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "ATM Gene Mutation" (1 trials), "ATR Gene Mutation" (1 trials) and "Adenocarcinoma of the Prostate" (1 trials). Many other conditions were trialed in "Ireland Cancer Center Landerbrook Health Center" in a lesser frequency.
Clinical Trials Intervention Types at Ireland Cancer Center Landerbrook Health Center
Most popular intervention types in "Ireland Cancer Center Landerbrook Health Center" are "Drug" (12 trials), "Other" (9 trials) and "Biological" (6 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (9 trials), "Docetaxel" (4 trials), "Durvalumab" (3 trials), "FGFR Inhibitor AZD4547" (2 trials) and "Ipilimumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Ireland Cancer Center Landerbrook Health Center
The vast majority of trials in "Ireland Cancer Center Landerbrook Health Center" are
11 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Ireland Cancer Center Landerbrook Health Center
Currently, there are NaN active trials in "Ireland Cancer Center Landerbrook Health Center".
undefined are not yet recruiting,
undefined are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Ireland Cancer Center Landerbrook Health Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Ireland Cancer Center Landerbrook Health Center, 1 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".